At present, we are pursuing a histochemical procedure supported by electron microscopic observations in an attempt to detect early neoplastic transformation in the liver long before the histologic or clinical appearance of hepatomas induced by carcinogenic agents. Our oncogenic findings as well as those of others using diethylnitrosamine, dimethyl aminoazobenzene, aflatoxin B have shown that the onset of
neoplasms in rat liver appeared in the form of individual cells then clearly delineated small islands of cells free of glucose-6phosphatase activity. This very early stage of preneoplastic transformation is histochemically detected weeks before it could be identified in routine sections stained with HE.
Electron microscopic studies of these newly transformed cells revealed characteristic features intermediate between those of normal hepatocytes and those of fully developed hepatoma cells. Among the changes in their cytoplasmic organelles indicative of neoplasms are: alteration of mitochondria, dilation and disruption of endoplasmic reticulum, dispersal of ribosomes, depletion of glycogen, presence of fibrillar inclusion structures, enlargement of the Golgi complex, increased lysosomes, disappearance of junctional complexes, widening of intercellular spaces and irregularity in the surface of the cell membrane.
Application of electron microscopy in the evaluation of drug safety during fetal development is indispensable. Effects of maternal intake of drugs may not be noted in the fetus until late after birth. In many instances, enzymatic and other biochemical approaches may not be conclusive because differentiation and maturation of some enzymes, especially those in the liver take place after birth. In such events, the electron microscope serves as an important tool in prediction of any change or abnormality in the cell organelles of tissues that often appear normal in the light microscope. We have examined fetal livers of rats under the effect of maternal intake of anti-inflammatory steroids (5, 6) , and under the influence of some bile acids such as lithocholic acid (7, 9) . All the livers appeared normal when examined by the light microscope but they showed drastic changes in the endoplasmic reticulum and mitochondria when examined electron microscopically. References 1. Zaki, F.G., Detzi Light or electron microscopic enzyme histochemistry gives information about the sites of action of enzymes or the lack of enzymes in cells and tissues. Under standardized reaction conditions it also permits quantitative estimations of the activity of an enzyme. Therefore, in enzyme histochemistry we have a very versatile tool for the investigation of the mechanisms of drug action and possible tissue damage. Since the enzymes are organ-species-and even sex-specific, it is not feasible to apply routinely all methods available except for two rather simple enzyme histochemical methods, acid and alkaline phosphatase. Both allow a wider application because of their systemic occurence. As a rule, simultaneous biochemical enzyme determinations are an advantage as they confirm and expand histochemical enzyme findings.
Acid Phosphatase
The reaction product of the acid phosphatase marks the lysosomal system, the so-called digestive tract of the cells. This cellular mechanism is shown on the diagram (Fig. 1 ) illustrating the three modes with which the digestive tract can act: storage, in our specific aspect, of engulfed indigestible substances, autophagy, and endocytosis of digestible macromolecular products.
It is well known that there are doubts about autophagy, because it is still not clear, whether dead cell areas are enveloped in every case by tubules of the rough endoplasmic reticulum or by lamellas of the Golgi-apparatus. It is also unclear, whether the acid hydrolases are formed here or-enter the autophagic vacuoles after fusion with the primary lysosomes. Each of these three chains can be activated individually, but it is not rare that two processes may occur simultaneously, if a test substance is given in high doses over a longer period of time. This is indicated by the two arrows between the secondary lysosomes. Autophagy certainly plays the most important role in the development of cell damage. This can be shown in two typical examples. High doses of heparinoids activate blood clotting. The activated products of this process are absorbed from the blood into RE-cells but also into liver cells. The next picture (Fig. 2 ) demonstrates the condition in the liver. The left side shows Kupffer cells with large amounts of PAS-positive material, and liver cells with round corpuscles of various sizes. On the right side there are large amounts of acid phosphatase reaction products, again in both Kupffer and liver cells. Here, the round corpuscles show varying degrees of acid phosphatase activity. These findings indicate that the activated clotting products are now present in the phagolysosomes where they undergo enzymatic degradation. At the peak of intracellular digestion, the enhanced activity of acid phosphatase can be determined in two ways; histochemically in the cell, and biochemically in the serum. At the time when the acid phosphatase is increased, biochemical methods will reveal high activity of proteases in homogenized liver tissue.
The second example refers to the kidney (Fig. 3 ). After intramuscular injections of an antiseptic or certain substances deposits of finely granulated material are found in the epithelium of the proximal convoluted tubules of the rat. The granules are pyronin-positive and can be almost totally digested by ribonuclease. This is shown on the right side of the picture. The activity of the acid phosphatase in these granules is increased. These findings manifest that the substance causes glomerular excretion and tubular absorption of RNA, but the question remains whether the absorption produces tubular damage at this stage. The higher magnification of the electron microscopic photo will answer this also for the first example ( Fig. 4 ). In this section of a proximal convoluted tubular cell, there are phagolysosomes with absorbed material some of which also contain mitochondria. Hence, besides endocytosis of a digestible substrate, there is also autophagy which means that degradation of cellular structures has occurred.
These two examples of the application of the acid phosphatase reaction are representative for many others, for instance, autophagy in myocardial cells in cardiopathy, autophagy due to cytotoxic effects, and storage of synthetic polymers in different organs e.g. the cells and macrophages of the liver.
A short remark should be made on species-and sexdifferences. The epithelia of the proximal tubules of rat and dog contain an abundance of lysosomes; however these organelles are found neither in the corresponding cells of the rhesus monkey nor in those of man on the application of enzyme histochemistry. Furthermore, the female rat has more lysosomes in these cells than the male. 
Alkaline Phosphatase
The alkaline phosphatase is predominantly localized on the absorbing and secreting surfaces of cells. Diminished or increased reaction products can therefore indicate reduced or lacking absorption or increased secretion. Two typical examples may best describe this picture. The left side of Fig. 5 shows marked focal loss of alkaline phosphatase in the epithelia of the proximal tubules of the dog kidney, and the the right presents the normal condition. Reabsorption in these areas has ceased. Fig. 6 Liver of male rats. Animal given high doses of a phenoxy alkanic acid derivative for 14 days (right). Left, untreated animal. Alkaline phosphatase (Gomori);
x 140.
The right side of Fig. 6 illustrates the diffuse increase of the reaction products of the alkaline phosphatase in the liver of the male rat. The normal condition is shown on the left. This increase in activity is commonly found after repeated administration of high doses of phenoxyalkanic acid derivatives. The finding concurs with an increase in serum alkaline phosphatase. The distribution of alkaline phosphatase in the liver is species-and sex-dependent. Hyperplasia of the epithelium of the rat bladder is another example. It is easily detectable by means of the reaction products of alkaline phosphatase. This is shown in Fig. 7 where the left side illustrates the changes as compared to the normal state on the right. The process progresses with continuous administration of this particular compound, ending in carcinoma of the bladder. The neoplastic transformation occurs within a relatively short time of treatment and with a high incidence of tumors in both rats and dogs. In contrast to this, the development of liver tumors is related to enzyme histochemical changes of the carbohydrate metabolism.
These two examples of carcinogenesis prove among many others that the most important and most revealing information is obtained from organ-and tissue-specific reactions. They also show the limitations of routine application of enzyme histochemistry to drug safety evaluations. After continued administration in relatively high doses active pharmacological or chemotherapeutical test substances can cause tissue changes or lesions in many different ways. These may be, for example the result of an excessive pharmacologic action or a correlated effect, impaired cytosynthesis up to and including disturbances in cell growth, a direct cytotoxic effect or even enzyme induction in liver cells induced by a metabolite of the drug. An investigation of most of these conditions therefore requires special enzyme histochemical methods. In drug safety evaluations they must be directed toward specific objects, preferably to an explanation of the mechanism causing the i mpai rment.
We gratefully acknowledge the technical assistance of Mrs. In this post Thalidomide decade, the need to prevent the introduction or to eliminate potential teratogenic risks to man and other species has been emphasized.
Recently, concerned groups have recommended that similar efforts be made to reduce potential mutagenic hazard. (8) This presentation is intended to summarize currently practiced or proposed laboratory animal testing procedures to satisfy these goals. While obvious questions are directed to the relevancy of experimental design, I do not plan to center debate concerning the merits of regulatory policy.
Much international concern and regulatory statements have been expressed, (3, 4, 15) however, my comments are drawn primarily from guidelines set forth by American government agencies. (6, 12) Subsequent to the recognition of the Thalidomide induced malformation syndrome in humans and animals in the early 1960's, empirical laboratory screening quidelines were reviewed and minimums re-defined. Animal tests required to support evaluation of pharmaceuticals in humans or the introduction of new chemical entities into the environment were stated. (11)
The reproduction and Teratology studies required for new pharmaceutical development are detailed in Figure 1 .
Although similar procedures apply to food additive and pesticide development, different emphasis is placed on the reproductive phases, experiments commonly including studies of medication through several successive generations.
Fertility and reproduction studies involve continuous parental medication through weaning. They include pre-mating medication in males and females. The goal is detection of adverse effects upon male and female fertility and/or effects upon gestation, parturition, lactation and neonatal growth and survival.
Assays for terotogenic potential usually require testing in two species and are commonly performed in rats, mice, rabbits or hamsters. Dogs, monkeys and guinea pigs have also been used. Dosage is administered to the dam during specific periods of organogenesis. The object is to detect treatment induced pathologic phenomena through morphologic examination of fetuses collected one day pre term. This includes thorough detailed macroscopic examination of fresh and preserved fetal viscera and carcasses and Alizarin stain fetal skeletal preparations. Fetal growth and viability are also evaluated.
The prenatal/postnatal studies evaluate effects of treatment during the last trimester of pregnancy and lactation upon fetal development and postnatal/neonatal growth and survival.
Amplifications of these studies beyond minimum requirements might include: 1) Duplicate or parallel fertility/reproduction studies in which sires and dams are medicated separately.
2) Pre-Teratology pilot studies performed to compare maternal and fetal adverse and/or lethal effect levels.
From these, the subsequent Teratology studies can be performed at dose levels the highest of which is in the range of maximum fetal or material tolerance.
3) Selection of test species based on similarity to humans in the biotransformation of the test substance.
4)
Similar evaluation performedon major metabolites as they are recognized in humans in addition to the substance originally administered.
Schematic summary of animal experiments required to support evaluation of pharmaceutics in humans.
As an example of the data generated for evaluation, Figure 2 outlines a complete series of reproduction and Teratology studies for one compound which might be performed and reported in 6 to 8 months. Approximately 8,500 individual sires, dams, embryos, fetuses and neonates will be examined, over 100,000 inputs of numerical data recorded and several thousand means and standard deviations calculated.
Considering examinations for pathologic phenomena, approximately 180,000 observations are performed and recorded from an estimated 1,300 fetuses. Data from histologic examinations would be an addition.
Included in this are data from concurrent controls and possible reference to previous laboratory control data. In addition, statistical testing should be included when appropriate to selected parameters.
When one considers the Teratogenicity studies for an example, the design performance the data evaluation are subject to multiple interdependent variables of great consequence as noted in Figure 3 in addition to those related to the species used.
Such complexities are dramatized by the research efforts to explore the mechanism of Thalidomide action upon the embryo. Much is yet to be clarified even though it has been examined by many disciplines of biology for the past decade. (13, 14) Further, it has been said that given the right conditions, any drug can be shown to be teratogenic in the proper species of animals. (7) * Based on Data Obtained During Evaluation of Several Investigational New Drug Entities.
In the past, major emphasis has been directed to detection of anatomical variants as indices of fetal injury. Reports detail effects noted 8 to 20 days after the basic insult and usually offer little insight into the intervening sequence of pathologic Regulations pertaining to food additives and pharmaceuticals have not as yet been stated, however, in depth review programs are currently in progress within various agencies presumably to specify guidelines for such investigations if required or performed.
Comparatively little broad based experience exists relating to the detection of chemical mutagenesis. No chemical mutagens are yet recognized in humans. Our ability to evaluate the mechanisms of induced heritable alterations in the genetic material of animals is also preliminary. (2) Mutagens are thought to induce two general effects, the most serious is the point or gene mutation in which heritable chemical alterations in DNA occur which are not sufficient to impair cell division or replication. The second effect is that of gross chromosomal aberration. The latter is regarded as less significant than point mutation since it tends to be self limiting as severely affected cells often die or fail to reproduce, however, heritable mutations may occur through restitution or exchange of broken chromosome portions. Breakage may also suggest that point mutations could occur at lower exposure levels and so forth. (5) At present, the three mammalian test procedures noted in Figure 4 seem to be likely initial candidates for use in mutagenic screening efforts. (8) They are the invivo cytogenetic assay, the dominant lethal test and the host mediated assay. Existing submammalian tests are considered less relevant. Recently, a rapid screening procedure of bone marrow has gained attention to demonstrate residual chromosome fragments in red cells as evidence of chromosome damage in less mature cells.
In addition to these tests is the requirement that subsequent generations be studied to detect persistence of effects or evidence of DNA repair mechanisms.
The invivo cytogenetic assay involves identifying chromosomal aberration, altered mitotic indices and mitotic processes in dividing bone marrow cells or gametocytes from animals previously exposed to levels of test substance. An experiment might involve approximately 50 metaphase plates examined per animal from 5 animals per group in a 5 to 6 group study. This is a tedious procedure requiring skilled personnel, replicate experiments and perhaps 4 to 6 months to execute. Obviously, this technique (2) has application to certain aspects of toxicological testing in humans or other species. Microscopic evidence of chromosomal aberration is sought through unbiased screening and karyotype study.
The dominent lethal test is considered a measure of chromosomal aberration as reflected by the failure of the conceptus to survive in untreated females. (1) Following acute, subacute or chronic administration to males, weekly matings are performed for 8 to 10 weeks to detect stages of male germ cell development which may be adversely affected. The status of pregnancy is measured in approximately 500 females. Consideration is given to implantation rates, early resorptions, numbers of dead and live fetuses as compared to concurrent control group values.
The most mediated assay is considered an indirect test for point mutation. (9) In can determine the ability of a mammal to potentiate or reduce an agent's mutagenic potential compared to its known invitro activity. An indicator system of known mutation frequency, such as tissue culture cell lines or selected bacterial strains is injected into the treated animal, incubated and the culture removed for further invitro culture, with examinations for mutation rate. The variables and complexities inherent to this particular test system are noteworthy.
As to their practical application, the tests for mutagenicity are best considered as being in development. Many obvious technical problems in execution must be solved, let alone developing confidence in interpretation before they become useful. 1.
Preliminary to inter-species extrapolation of relevance to humans, efforts in both mutagenic and teratogenic screening are faced by a question of comparable significance. Has the target, the developing fetus, neonate, gonadal tissue or indeed chromosome structure received sufficient challenge through effective and appropriate test system use? If not, then what significance should be attached to the lack of effect or negative data within that species?
Concerns to avoid teratogenic and mutagenic risk cannot be ignored; accomplishments thus far can be regarded as steps in the right direction, yet the relevance of animal screening tests to the human situation needs much further exploration.
Finally and not to be forgotten, is the potential risk that mankind will be denied useful chemical entities through ultraconservative attitudes.
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